Castle Biosciences, Inc. (CSTL)
25.00
-0.70
(-2.72%)
USD |
NASDAQ |
Mar 20, 16:00
25.03
+0.03
(+0.12%)
After-Hours: 20:00
Castle Biosciences EPS Diluted (Quarterly) : -0.0795 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.172 |
| Delcath Systems, Inc. | -0.052 |
| Assertio Holdings, Inc. | -1.858 |
| CorMedix, Inc. | 0.1493 |
| Harmony Biosciences Holdings, Inc. | 0.3831 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.332M |
| Revenue (Quarterly) | 87.01M |
| Total Expenses (Quarterly) | 89.34M |
| Enterprise Value | 480.79M |
| Gross Profit Margin (Quarterly) | 75.87% |
| Profit Margin (Quarterly) | -2.68% |
| Earnings Yield | -3.39% |
| Normalized Earnings Yield | -3.481 |